Clinical studies and article & posters
• Asian Association of Hair Restoration Surgeons
2nd Annual Scientific Meeting
2012. 5. 11~13
[Advantages in Utilizing growth factors in hair transplantation]
This is an example of treatment using AGF39
to increase the rate of engraftment and patient satisfaction before and after hair transplantation.
• Journal of Dermatology 2012
Journal of Dermatology 2012: 39: 1-2
11 Korean Women (41±2 years) into Ludwig I grade, Random, double-blind test.
It is very unusual for SCI to publish a clinical trial of cosmetic products.
Growth factor solution (SGF57 -> AGF39 at present) was topically applied on the treated half of the scalp and followed by microneedle therapy.
The other half of the scalp (control) was treated with normal saline followed by microneedle therapy.
※ Clinical photos of patient 1
The changes in hair shaft count
The rate of change on the treated side was significantly different from that on the control side.
• At 7th World Congress for Hair research 2013, Edinburgh
• At 8th World Congress for Hair research 2014, Jeju, Korea
This is a clinical result that proves that there is a difference in the effect proportional to the increase of the drug absorption rate according to the depth of the needle.
• Effects of AesMed's cytokine therapy
Currently, we have more than 15,000 cases per month in 500 clinic centers including 7 domestic university hospitals, hair transplant clinics, and hair loss care dermatology.
※ Clinical photograph